Neuberger Berman Group »

Recursion Pharmaceuticals shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.7M 356k 7.50

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Nvidia Corp Common (NVDA)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc-cl C Common (GOOG)
Alphabet Inc Class A A Common (GOOGL)
Eli Lilly & Co Common (LLY)
Berkshire Hathaway Inc Class B Common (BRK.B)
September 24 Puts on SNPS US Option Put Option (SNPS)
Nextera Energy Common (NEE)
T Mobile Us Common (TMUS)
Meta Platforms Inc-class A Common (META)
Procter & Gamble Co/the Common (PG)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
Kinnevik AB
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
State Street Corporation
MIC Capital Management UK
Nvidia Corp
Geode Capital Management
Exor Investments

View all funds holding Recursion Pharmaceuticals